000 01353 a2200349 4500
005 20250513203039.0
264 0 _c20000307
008 200003s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-200002000-00009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOleksowicz, L
245 0 0 _aSustained ventricular tachycardia and its successful prophylaxis during high-dose bolus interleukin-2 therapy for metastatic renal cell carcinoma.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cFeb 2000
300 _a34-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAnti-Arrhythmia Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xadverse effects
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSotalol
_xtherapeutic use
650 0 4 _aTachycardia, Ventricular
_xchemically induced
700 1 _aEscott, P
700 1 _aLeichman, G C
700 1 _aSpangenthal, E
773 0 _tAmerican journal of clinical oncology
_gvol. 23
_gno. 1
_gp. 34-6
856 4 0 _uhttps://doi.org/10.1097/00000421-200002000-00009
_zAvailable from publisher's website
999 _c10637357
_d10637357